Learn about the Serum Institute of India manufacturing the Oxford Ebola vaccine, backed by US$ 8.6 million CEPI funding, and its significance in global health.
Category: Vaccine Development
Moderna and CEPI Expand Collaboration to Include Bundibugyo Ebolavirus Vaccine
Moderna and CEPI expand collaboration to include development of vaccine against Bundibugyo ebolavirus, a highly infectious and deadly virus.
